LORLATINIB
B7461006
Phase 3 small_molecule active
Quick answer
LORLATINIB for Advanced ALK positive non-small cell lung cancer is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Advanced ALK positive non-small cell lung cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active